Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Journal of Biopharmaceutical Statistics
|
June 22, 2013
Bayesian sample size determination for a clinical trial with correlated continuous and binary outcomes
James D Stamey, Fanni Natanegara, John W Seaman
Clinical Pharmacology and Therapeutics
|
July 25, 2023
Design and Execution of Sustainable Decentralized Clinical Trials
Pritibha Singh, Andrea M Burden, Fanni Natanegara, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 30, 2014
Estimation of the inter- and intrasubject variability of the diurnal serum cortisol rhythm in healthy male subjects to evaluate the biomarker potential for drug target engagement
Fanni Natanegara, Adrienne Tran, Stephen Lowe, et al.
The Journal of Sexual Medicine
|
February 29, 2008
Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States
Ira D Sharlip, Bryan P Shumaker, Lawrence S Hakim, et al.
Pharmaceutical Statistics
|
September 13, 2013
The current state of Bayesian methods in medical product development: survey results and recommendations from the DIA Bayesian Scientific Working Group
Fanni Natanegara, Beat Neuenschwander, John W Seaman, et al.
Journal of Biopharmaceutical Statistics
|
August 7, 2015
Bayesian methods for the design and analysis of noninferiority trials
Margaret Gamalo-Siebers, Aijun Gao, Mani Lakshminarayanan, et al.
Therapeutic Innovation & Regulatory Science
|
January 3, 2022
Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development
, Jennifer Clark, Natalia Muhlemann, et al.
Therapeutic Innovation & Regulatory Science
|
December 10, 2022
Why are There not More Bayesian Clinical Trials? Ability to Interpret Bayesian and Conventional Statistics Among Medical Researchers
, Ross Bray, Andrew Hartley, et al.
The Journal of Sexual Medicine
|
May 10, 2006
Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design
Abraham Morgentaler, James Barada, Craig Niederberger, et al.
Journal of Alzheimer'S Disease Reports
|
June 11, 2021
Phase II (NAVIGATE-AD study) Results of LY3202626 Effects on Patients with Mild Alzheimer's Disease Dementia
Albert C Lo, Cynthia Duggan Evans, Michele Mancini, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Journal of Biopharmaceutical Statistics
|
June 22, 2013
Bayesian sample size determination for a clinical trial with correlated continuous and binary outcomes
James D Stamey, Fanni Natanegara, John W Seaman
Clinical Pharmacology and Therapeutics
|
July 25, 2023
Design and Execution of Sustainable Decentralized Clinical Trials
Pritibha Singh, Andrea M Burden, Fanni Natanegara, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 30, 2014
Estimation of the inter- and intrasubject variability of the diurnal serum cortisol rhythm in healthy male subjects to evaluate the biomarker potential for drug target engagement
Fanni Natanegara, Adrienne Tran, Stephen Lowe, et al.
The Journal of Sexual Medicine
|
February 29, 2008
Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States
Ira D Sharlip, Bryan P Shumaker, Lawrence S Hakim, et al.
Pharmaceutical Statistics
|
September 13, 2013
The current state of Bayesian methods in medical product development: survey results and recommendations from the DIA Bayesian Scientific Working Group
Fanni Natanegara, Beat Neuenschwander, John W Seaman, et al.
Journal of Biopharmaceutical Statistics
|
August 7, 2015
Bayesian methods for the design and analysis of noninferiority trials
Margaret Gamalo-Siebers, Aijun Gao, Mani Lakshminarayanan, et al.
Therapeutic Innovation & Regulatory Science
|
January 3, 2022
Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development
, Jennifer Clark, Natalia Muhlemann, et al.
Therapeutic Innovation & Regulatory Science
|
December 10, 2022
Why are There not More Bayesian Clinical Trials? Ability to Interpret Bayesian and Conventional Statistics Among Medical Researchers
, Ross Bray, Andrew Hartley, et al.
The Journal of Sexual Medicine
|
May 10, 2006
Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design
Abraham Morgentaler, James Barada, Craig Niederberger, et al.
Journal of Alzheimer'S Disease Reports
|
June 11, 2021
Phase II (NAVIGATE-AD study) Results of LY3202626 Effects on Patients with Mild Alzheimer's Disease Dementia
Albert C Lo, Cynthia Duggan Evans, Michele Mancini, et al.
Page
of 3